Federal Register / Vol. 88, No. 168 / Thursday, August 31, 2023 / Notices 60219 

TABLE 1—RECIPIENTS AND AWARD AMOUNTS

Grant No. Award recipient name City, state Award 

amount 

UF5MC32750 .......................... National Institute for Children’s Health Quality ........................ Boston, MA ............................. $1,900,000 

Justification: HRSA will provide 

supplemental award funds to the 

current SHSPP recipient in fiscal year 

2023 to provide new and continued 

support to Healthy Start grant 

recipients. The current recipient of the 

SHSPP is best positioned to address the 

objectives that to be supported by the 

supplemental funds, including 

supporting data collection and 

evaluation and implementing applicable 

Executive Orders. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–18798 Filed 8–30–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

HRSA-Initiated Supplemental Funding 

to the Supporting Maternal Health 

Innovation Program 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice of supplemental award. 

SUMMARY: HRSA is providing 

supplemental funds not to exceed 

$1,500,000 to the Supporting Maternal 

Health Innovation Program, also 

referred to as the Maternal Health 

Learning and Innovation Center 

(MHLIC), in fiscal year (FY) 2023 to 

provide support and capacity building 

to HRSA’s new maternal health award 

recipients under the State Maternal 

Health Innovation (MHI) Program 

(HRSA–23–108). 

FOR FURTHER INFORMATION CONTACT: 

Kimberly Sherman, Chief, Maternal and 

Women’s Health Branch, Division of 

Healthy Start and Perinatal Services, 

Maternal and Child Health Bureau, 

HRSA, at ksherman@hrsa.gov or (301) 

443–1702. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: One 

award to the University of North 

Carolina at Chapel Hill, the current 

recipient under the Supporting Maternal 

Health Innovation Program, now known 

as MHLIC, as listed in Table 1. 

Amount of Non-Competitive Award: 

Up to $1,500,000. 

Project Period: September 30, 2019, to 

September 29, 2024. 

CFDA Number: 93.110. 

Award Instrument: Supplement. 

Authority: 42 U.S.C. 701(a)(2) (title V, 

section 501(a)(2) of the Social Security 

Act). 

TABLE 1—SUPPORTING MHI PROGRAM AWARD RECIPIENT (2019–2024) 

Grant No. Grantee organization City, state Award 

amount 

U7CMC33636 University of North Carolina at Chapel Hill ..................................................................................... Raleigh, NC ... $1,500,000 

Justification: The Consolidated 

Appropriations Act, 2023 (Pub. L. 117– 

328) included additional Special 

Projects of Regional and National 

Significance funding. The Explanatory 

Statement accompanying the 

Consolidated Appropriations Act 

specified a $26 million increase for the 

State MHI Program to establish new 

cooperative agreements in FY 2023 with 

up to 23 new states. MHLIC provides 

support and capacity building to 

HRSA’s maternal health award 

recipients. Supplemental funds to 

MHLIC will be used to provide support 

and capacity building to the new cohort 

of FY 2023 State MHI award recipients. 

The requested activities are within 

scope of the Supporting Maternal Health 

Innovation Program. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–18799 Filed 8–30–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK SEP High 

Risk Multi-Center Clinical Study Cooperative 

Agreement U01. 

Date: September 28, 2023. 

Time: 12:00 p.m. to 1:00 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Cheryl Nordstrom, Ph.D., 

MPH, Scientific Review Officer, NIDDK/ 

Scientific Review Branch, National Institutes 

of Health, 6707 Democracy Blvd., Room 

7013, Bethesda, MD 20892, 301–402–6711, 

cheryl.nordstrom@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 


ddrumheller on DSK120RN23PROD with NOTICES1